Further investigations combining transcriptome profiling with high-resolution epigenome mapping in RCC can shed light on molecular mechanisms by which KDM5C contributes to ccRCC, and may lead to novel therapeutic interventions. The gene discussed is KDM5C; the disease is nonpapillary renal cell carcinoma.